SCHEMBL9005641

SCHEMBL9005641

CC(C)c1cc(C(=O)O)ccc1C1CCCCCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 1/20 0.53
ACE2 Q9BYF1 2/20 0.43
PTGDR2 Q9Y5Y4 3/20 0.42
PTGDR Q13258 1/20 0.42
CREBBP Q92793 1/20 0.41
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
POLB P06746 1/20 0.40
KMT2A Q03164 1/20 0.40
SRD5A2 P31213 1/20 0.40
CNR2 P34972 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HSD17B10 Q99714 1/20 0.39
GAA P10253 1/20 0.39
S1PR1 P21453 1/20 0.39
RXRA P19793 2/20 0.38
HCAR3 P49019 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CYP2D6 P10635 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31401258 0.81 CREBBP (0.46) KMOACE2CREBBPMEN1ALDH1A1
SCHEMBL4951622 0.80 KMO (0.57) KMOPTGDR2CREBBPMEN1ALDH1A1
SCHEMBL25486915 0.80 ACE2 (0.50) KMOACE2CREBBPMEN1ALDH1A1
SCHEMBL3144099 0.78 ANPEP (0.38) PTGDR2PTGDRMEN1ALDH1A1KMT2A
SCHEMBL4946903 0.78 KMO (0.54) KMOPTGDR2CREBBPMEN1ALDH1A1
SCHEMBL1398501 0.77 KMO (0.54) KMOPTGDR2CREBBPMEN1ALDH1A1
SCHEMBL13957843 0.76 KMO (0.57) KMOCREBBPMEN1ALDH1A1POLB
SCHEMBL11674643 0.76 KMO (0.57) KMOPTGDR2PTGDRMEN1ALDH1A1
SCHEMBL3902715 0.76 KMO (0.57) KMOPTGDR2CREBBPMEN1ALDH1A1
SCHEMBL18304697 0.76 KMO (0.53) KMOPTGDR2CREBBPSRD5A2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0579223-B1 Carboxylic acid derivatives having 5 alpha-reductase inhibitory activity MITSUBISHI CHEM CORP (JP) 1996-10-09 EP disclosed
US-5385917-A Treating androgen dependent diseases MITSUBISHI KASEI CORPORATION (JP) 1995-01-31 US disclosed
EP-0579223-A1 Carboxylic acid derivatives having 5 alpha-reductase inhibitory activity Mitsubishi Chemical Corporation (JP) 1994-01-19 EP disclosed